Even though insulin therapy (administered through multiple daily subcutaneous injections via insulin pens or through continuous subcutaneous infusion via insulin pumps) remains the mainstay of T1D management [42], it is associated with an increased risk of hypoglycemia and weight gain [43,44]. Here, INS is linked to Hypoglycemia.